SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016534
Filing Date
2019-05-07
Accepted
2019-05-07 16:22:43
Documents
53
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-10q_20190331.htm 10-Q 1500822
2 EX-31.1 vrca-ex311_7.htm EX-31.1 15034
3 EX-31.2 vrca-ex312_9.htm EX-31.2 14969
4 EX-32.1 vrca-ex321_8.htm EX-32.1 11190
  Complete submission text file 0001564590-19-016534.txt   5426514

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vrca-20190331.xml EX-101.INS 1235557
6 XBRL TAXONOMY EXTENSION SCHEMA vrca-20190331.xsd EX-101.SCH 35745
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrca-20190331_cal.xml EX-101.CAL 40007
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrca-20190331_def.xml EX-101.DEF 137866
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20190331_lab.xml EX-101.LAB 287630
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20190331_pre.xml EX-101.PRE 229951
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 19803438
SIC: 2834 Pharmaceutical Preparations